Published 23 September 2026
What happens between a pharmaceutical product and the patient who needs it?
In Part 1 of this Pharma Talks conversation, Nataliya Andreychuk sits down with Richard Schwartz, a healthcare and pharmaceutical industry expert with three decades of experience across pharma, consulting, agencies, publishing and technology, to explore one of the industry's biggest blind spots: the experience surrounding the medicine.
The conversation goes deeper into trust in pharma, patient-centricity, healthcare customer experience, patient support programs and why experience should be treated as part of the product — not an extra layer added after the medicine is developed.
Monday, 2 Nov 2026
Monday, 2 Nov 2026
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Reading this content is completely free
Already have an account? Sign in